Everest Clinical Research Acquires Brightech International
December 2, 2022
Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.
- Targets
- Brightech International
- Platforms
- Everest Clinical Research
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.